Ciltistotug
Ciltistotug is a monoclonal antibody targeting human CD40 (TNFRSF5) . Ciltistotug activates immune cells after binding to CD40, exerting immunostimulatory and antitumor activities. Ciltistotug is promising for research of cancer immunotherapy[1].
Product Specifications
CAS Number
3014361-59-9
UNSPSC
12352203
Target
TNF Receptor
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Smiles
[Ciltistotug]
References & Citations
[1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
